e-learning
resources
Milan 2017
Monday, 11.09.2017
Cystic fibrosis: treatments and monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LCI in young children with CF – N2 or SF6?
M. Stahl (Heidelberg, Germany)
Source:
International Congress 2017 – Cystic fibrosis: treatments and monitoring
Session:
Cystic fibrosis: treatments and monitoring
Session type:
Poster Discussion
Number:
1839
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Stahl (Heidelberg, Germany). LCI in young children with CF – N2 or SF6?. 1839
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Open label case-control study to assess Pidotimod efficacy in Non CF Bronchiectasis Disease: a pilot study
Related content which might interest you:
Cross-sectional and longitudinal comparison of N2 and SF6 multiple breath washout in infants and toddlers with CF and healthy controls
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Single-breath lung diffusion capacity for carbon monoxide in children and young adults born extremely preterm
Source: Annual Congress 2011 - New insights in paediatric respiratory physiology
Year: 2011
Outcome of multiple breath washout (MBW) in healthy children using two different gases (N2 and SF6) with the same equipment
Source: International Congress 2017 – What is new in respiratory and sleep physiology?
Year: 2017
Measurement of functional residual capacity (FRC) in infants and young children using an ultrasonic flowmeter for SF6 multiple breath washing/washout
Source: Eur Respir J 2002; 20: Suppl. 38, 19s
Year: 2002
Longitudinal SF6 multiple breath washout in infants and toddlers with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Over-reading of FRC using N2 MBW compared to plethysmography and SF6 MBW in COPD
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
Monitoring of young children with CF
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Prediction equations for carbon monoxide diffusing capacity of the lung (T
L,CO
) in healthy Bulgarian children aged 7 to 18 years
Source: International Congress 2014 – New aspects of lung function testing in children
Year: 2014
Assessment of diffusion capacity (TLCO) by the rebreathing method in healthy young children: preliminary results
Source: Eur Respir J 2002; 20: Suppl. 38, 224s
Year: 2002
"Effects" of bronchiolitis on ventilation inhomogeneity (VI) at preschool age: comparison of Multiple Breath Washout (MBW) between post-bronchiolitis, cystic fibrosis and healthy children
Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives
Year: 2018
Long-term lung clearance index (LCI) monitoring in young children with CF
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007
Comparison of ventilation inhomogeneity assessed by VC and tidal breath inert gas washout in children with mild-to-severe CF lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 347s
Year: 2001
Prediction equations for carbon monoxide lung transfer in caucasian healthy children using the rebreathing method
Source: Annual Congress 2006 - New developments in infant and intensive care lung function
Year: 2006
Pulmonary gas transfer in children and adolescents born extremely preterm
Source: Eur Respir J 2013; 42: 1536-1544
Year: 2013
Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis
Source: Eur Respir J 2003 Dec 01;22(6):972-979
Year: 2003
Normative data for the new setup of the SF6 multiple-breath washout in unsedated infants
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018
Spirometry and multiple breath nitrogen washout (MBNW) before and after cold dry air challenge (CACh) in children and adolescents with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Long-range correlations of breath to breath tidal volume (
VT
), end-tidal O
2
and CO
2
of healthy infants compared to infants with chronic lung disease (CLD)
Source: Eur Respir J 2001; 18: Suppl. 33, 346s
Year: 2001
Development of an exhaled breath protein pattern to distinguish asthmatic from healthy children
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Relationships between FRCHe, trapped gas and PaO2 in children with chronic bronchial diseases
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept